Published in Intervirology on January 01, 1983
Hepatitis E virus: animal reservoirs and zoonotic risk. Vet Microbiol (2009) 3.12
Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci U S A (1992) 2.64
Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol (1997) 2.25
Hepatitis E virus infection. Clin Microbiol Rev (2014) 2.21
Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis (2003) 2.03
Hepatitis E virus: identification of type-common epitopes. J Virol (1991) 1.95
Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent. Proc Natl Acad Sci U S A (1994) 1.90
Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol (2012) 1.89
A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. J Virol (2006) 1.74
Hepatitis viruses: changing patterns of human disease. Proc Natl Acad Sci U S A (1994) 1.60
Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol (2002) 1.58
Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol (2007) 1.58
A systematic review of the epidemiology of hepatitis E virus in Africa. BMC Infect Dis (2014) 1.55
Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc Natl Acad Sci U S A (2001) 1.54
Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Microbiol (2000) 1.53
Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm viruslike particles. Proc Natl Acad Sci U S A (1987) 1.50
Virus-specific mRNA capping enzyme encoded by hepatitis E virus. J Virol (2001) 1.47
Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J Virol (2005) 1.43
Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem (2010) 1.40
Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A (1994) 1.38
An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients. Transfusion (2013) 1.36
Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells. J Clin Microbiol (1993) 1.32
Hepatitis E virus. BMJ (1990) 1.25
Systematic pathogenesis and replication of avian hepatitis E virus in specific-pathogen-free adult chickens. J Virol (2005) 1.20
Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis (2012) 1.18
Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. J Virol (2007) 1.16
Prevalence of hepatitis E virus antibodies in Canadian swine herds and identification of a novel variant of swine hepatitis E virus. Clin Diagn Lab Immunol (2001) 1.14
Epidemiology and risk factors of incident hepatitis E virus infections in rural Bangladesh. Am J Epidemiol (2010) 1.09
Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses. J Gen Virol (2011) 1.09
Human linear B-cell epitopes encoded by the hepatitis E virus include determinants in the RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A (1992) 1.08
Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay. Clin Diagn Lab Immunol (2003) 1.07
Identification of novel human hepatitis E virus (HEV) isolates and determination of the seroprevalence of HEV in Korea. J Clin Microbiol (2005) 1.05
Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays. BMC Infect Dis (2012) 1.05
Hepatitis E: Epidemiology and prevention. World J Hepatol (2011) 1.01
Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J Clin Microbiol (2007) 0.99
Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF. Proteome Sci (2011) 0.97
Host immune status and response to hepatitis E virus infection. Clin Microbiol Rev (2014) 0.96
Overview of Hepatitis E Virus. Curr Infect Dis Rep (2002) 0.95
Expression of hepatitis E virus putative structural proteins in recombinant vaccinia viruses. Clin Diagn Lab Immunol (1994) 0.92
A Novel Astrovirus-Like RNA Virus Detected in Human Stool. Virus Evol (2016) 0.91
Prevalence of hepatitis e virus in swine fed on kitchen residue. PLoS One (2012) 0.90
Current Knowledge on Hepatitis E. J Clin Transl Hepatol (2015) 0.89
A Population-based Seroepidemiological Study on Hepatitis E Virus in Iran. Middle East J Dig Dis (2010) 0.89
Hepatitis E: a complex and global disease. Emerg Health Threats J (2008) 0.89
Hepatitis e: epidemiology and natural history. J Clin Exp Hepatol (2013) 0.88
Naturally occurring animal models of human hepatitis E virus infection. ILAR J (2014) 0.88
Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3. Clin Vaccine Immunol (2007) 0.87
Relationships among viral diagnostic markers and markers of liver function in acute hepatitis E. J Gastroenterol (2009) 0.87
Clinical features and risk factors of acute hepatitis E with severe jaundice. World J Gastroenterol (2012) 0.86
Hepatitis E Virus. Transfus Med Hemother (2008) 0.86
Transmission of Hepatitis E Virus in Developing Countries. Viruses (2016) 0.83
Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection. Am J Trop Med Hyg (2014) 0.83
Water borne hepatitis a and hepatitis e in malwa region of punjab, India. J Clin Diagn Res (2013) 0.83
Population Movement and Virus Spreading: HEV Spreading in a Pilgrimage City, Mashhad in Northeast Iran; an Example. Hepat Mon (2013) 0.82
Epidemiology of Hepatitis E Virus in European Countries. Int J Mol Sci (2015) 0.82
Hepatitis E Virus Mutations: Functional and Clinical Relevance. EBioMedicine (2016) 0.82
Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then. Hepatol Int (2010) 0.81
Purification of a baculovirus-expressed hepatitis E virus structural protein and utility in an enzyme-linked immunosorbent assay. J Clin Microbiol (1995) 0.81
Hepatitis e: molecular virology and pathogenesis. J Clin Exp Hepatol (2013) 0.80
Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts. Protein Sci (2013) 0.79
Outbreak of Viral Hepatitis E in a Regimental Training Centre. Med J Armed Forces India (2011) 0.79
Hepatitis E Virus. Transfus Med Hemother (2015) 0.78
Experimental infection of Z:ZCLA Mongolian gerbils with human hepatitis E virus. World J Gastroenterol (2015) 0.78
Viral hepatitis and the surgeon. HPB (Oxford) (2005) 0.77
Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection. J Gastroenterol (2007) 0.77
Ancient recombination events and the origins of hepatitis E virus. BMC Evol Biol (2016) 0.76
Genome sequence of a hepatitis e virus of genotype 3e from a chronically infected kidney transplant recipient. Genome Announc (2014) 0.76
A survey on the status of hepatitis e virus infection among slaughterhouse workers in South Korea. J Prev Med Public Health (2015) 0.76
Hepatitis E Virus. Transfus Med Hemother (2009) 0.76
Outbreak of hepatitis E virus infection in Darfur, Sudan: effectiveness of real-time reverse transcription-PCR analysis of dried blood spots. J Clin Microbiol (2009) 0.76
Molecular detection of hepatitis E virus in rivers in the Philippines. Am J Trop Med Hyg (2014) 0.76
Hepatitis Vaccines. Vaccines (Basel) (2016) 0.76
Molecular Biology and Infection of Hepatitis E Virus. Front Microbiol (2016) 0.75
The WASH approach: fighting waterborne diseases in emergency situations. Environ Health Perspect (2015) 0.75
The relationship between serology of hepatitis E virus with liver and kidney function in kidney transplant patients. EXCLI J (2016) 0.75
Hepatitis E virus: Current epidemiology and vaccine. Hum Vaccin Immunother (2016) 0.75
Hepatitis E in Israel: A nation-wide retrospective study. World J Gastroenterol (2016) 0.75
A Case Report About the Most Common Yet Most Forgotten Hepatitis E. Am J Case Rep (2016) 0.75
A Comparative Study of Assay Performance of Commercial Hepatitis E Virus Enzyme-Linked Immunosorbent Assay Kits in Australian Blood Donor Samples. J Blood Transfus (2016) 0.75
Therapeutic targets for the treatment of hepatitis E virus infection. Expert Opin Ther Targets (2015) 0.75
A Single Lineage of Hepatitis E Virus Causes Both Outbreaks and Sporadic Hepatitis in Sudan. Viruses (2016) 0.75
Hepatitis E. BMJ (1995) 0.75
Extended Microbiological Characterization of Göttingen Minipigs in the Context of Xenotransplantation: Detection and Vertical Transmission of Hepatitis E Virus. PLoS One (2015) 0.75
Acute Hepatitis E: Two Sides of the Same Coin. Viruses (2016) 0.75
Enteric hepatitis viruses. Gastroenterol Hepatol Bed Bench (2012) 0.75
Hepatitis E: Discovery, global impact, control and cure. World J Gastroenterol (2016) 0.75
Viral hepatitis. Gut (1991) 0.75
Hepatitis E Virus in Industrialized Countries: The Silent Threat. Biomed Res Int (2016) 0.75
Non-A, non-B hepatitis: dead ends or new horizons? Br Med J (Clin Res Ed) (1987) 0.75
Synthetic rabbit-human antibody conjugate as a control in immunoassays for immunoglobulin M specific to hepatitis E virus. Virol J (2010) 0.75
Structure determination of a human virus by the combination of cryo-EM and X-ray crystallography. Biophys Rep (2016) 0.75
Zoonotic Hepatitis E Virus: Classification, Animal Reservoirs and Transmission Routes. Viruses (2016) 0.75
Detection of Hepatitis E Virus Antibodies in Dogs in the United Kingdom. PLoS One (2015) 0.75
Health economic evaluation of immunization strategies of hepatitis E vaccine for elderly population. Hum Vaccin Immunother (2017) 0.75
The characterization of the quasi-enveloped hepatitis E virus particles released by the cellular exosomal pathway. J Virol (2017) 0.75
Taxonomy of the caliciviruses. J Infect Dis (2000) 3.94
Factors affecting the efficacy of live poliovirus vaccine in warm climates. Efficacy of type 1 Sabin vaccine administered together with antihuman gamma-globulin horse serum to breast-fed and artificially fed infants in Uganda. Bull World Health Organ (1974) 1.88
Simian hepatitis A virus (HAV) strain AGM-27: comparison of genome structure and growth in cell culture with other HAV strains. J Gen Virol (1991) 1.05
Virus of enterically transmitted non-A, non-B hepatitis. Lancet (1988) 1.01
Identification of precursors of structural proteins VP1 and VP2 of hepatitis A virus. J Med Virol (1992) 0.96
Virus-specific antibody titres in different phases of hepatitis C virus infection. J Viral Hepat (2002) 0.95
[Nosological classification of bokhoror]. Genetika (1977) 0.88
Shifts in the rates and levels of antibody to hepatitis A virus associated with hepatitis A infection in children's communities. Eur J Epidemiol (1987) 0.88
[New data on the viral agent of Crimean hemorrhagic fever]. Vopr Virusol (1969) 0.88
Non-A, non-B fulminant viral hepatitis in France in returnees from Asia and Africa. Dig Dis Sci (1987) 0.86
Hepatitis E virus infection in chimpanzees: a retrospective analysis. Arch Virol (2000) 0.86
[Viremia in influenza A2 (Hong Kong)]. Vopr Virusol (1971) 0.85
[Reproduction in monkeys of non-A, non-B hepatitis transmitted via the fecal and oral routes]. Vopr Virusol (1986) 0.83
Improvement of methods for intratypic differentiation of polioviruses. II. Use of strain-specific antisera cross-adsorbed with antigens of heterologous strains in agar gel diffusion precipitation test for differentiation between wild and vaccine strains of poliovirus typess 1,2 and 3. Arch Gesamte Virusforsch (1974) 0.81
Improvement of methods for intratypic differentiation of polioviruses. III. Neutralization test with cross-adsorbed sera for differentiation between wild and vaccine strains of polioviruses. Arch Gesamte Virusforsch (1974) 0.81
[Spontaneous hepatitis similar to hepatitis A in African green monkeys]. Vopr Virusol (1988) 0.80
Detection of viral antigen by autoradiography and immunofluorescence in epithelial cells of the respiratory tract in natural and experimental influenza infection. Acta Virol (1966) 0.80
[The role of Coxsackie viruses in the pathogenesis of diffuse toxic goiter]. Probl Endokrinol (Mosk) (1989) 0.79
Hepatitis E virus in cultivated cells. Arch Virol (1992) 0.79
An outbreak of influenza B in a closed community school in Uganda. East Afr Med J (1977) 0.78
Characteristics of inactivated hepatitis A vaccine prepared from virus propagated in heteroploid continuous monkey cell line. Vaccine (1990) 0.77
[Characteristics of viral hepatitis non-A, non-B with a fecal-oral mechanism of transmission of the infection in southern Uzbekistan]. Vopr Virusol (1989) 0.77
[Results of combined therapy using levamisole for patients with influenza complicated by pneumonia]. Vopr Virusol (1984) 0.77
[Molecular biology of hepatitis B virus]. Vopr Virusol (1982) 0.76
Pathogenesis of experimental Crimean hemorrhagic fever infection in newborn white mice. Acta Virol (1973) 0.75
Some characteristics of poliovirus strains isolated in Uganda between 1966 and 1971. Bull World Health Organ (1976) 0.75
Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers. Vaccine (1991) 0.75
The spread of hepatitis A virus in connection with hepatitis cases in children's communities. Bull World Health Organ (1982) 0.75
[Detection of antibodies to surface (anti-HBs) and core (anti-HBc) antigens of hepatitis B virus by the fluorescent antibody technic]. Vopr Virusol (1982) 0.75
[Comparative clinical study of acute respiratory virus diseases]. Vestn Akad Med Nauk SSSR (1968) 0.75
[Mycoplasmic infection in pneumonia complicating viral respiratory disease]. Ter Arkh (1976) 0.75
[Clinical study of latent and chronic viral infections]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Functional state of the respiratory system in acute respiratory virus diseases with asthmatic syndrome in young children]. Vopr Okhr Materin Det (1974) 0.75
[New immunological test (SH-antigen) in viral hepatitis]. Vestn Akad Med Nauk SSSR (1971) 0.75
[Current methods for the diagnosis of respiratory virus infections in young children]. Vestn Akad Med Nauk SSSR (1966) 0.75
[Clinical aspects and diagnosis of pharyngitis in adults with parainfluenzal diseases]. Vestn Otorinolaringol (1970) 0.75
[Use of the throbocyte aggregation test for diagnosis of human cytomegalovirus infection]. Vopr Virusol (1974) 0.75
[Markers of hepatitis-viral infection in children born of mothers with hepatitis B]. Vopr Virusol (1982) 0.75
[Modelling of acute liver failure in rabbits]. Biull Eksp Biol Med (1982) 0.75
[A discriminant method for the differential diagnosis of para-influenza and adenovirus diseases in children]. Vopr Virusol (1969) 0.75
[Recognition of influenza and other acute respiratory virus infections and their combinations by means of immunofluorescence]. Vopr Virusol (1976) 0.75
[Attempts to isolate the components of the virus of serum hepatitis in isolated mitochondria]. Vestn Akad Med Nauk SSSR (1973) 0.75
[Influenza A2 (England) 72 (clinical picture and treatment)]. Ter Arkh (1973) 0.75
[Functional status of the bronchi in influenza and para-influenza]. Sov Med (1968) 0.75
[Respiratory syncytial virus infection in adults]. Klin Med (Mosk) (1974) 0.75
[Immunofluorescence method of determining HBc-antibodies in the blood sera of serum hepatitis type B patients]. Vopr Virusol (1979) 0.75
[Use of the immunofluorescence test in the differential diagnosis of acute and latent adenovirus infections in adult]. Vopr Virusol (1976) 0.75
[Specific class M immunoglobulins in viral hepatitis A patients (their diagnostic and prognostic significance)]. Vopr Virusol (1982) 0.75
[Use of the immunofluorescence technique for detecting antigens in the liver cells of patients with infectious hepatitis]. Vopr Virusol (1969) 0.75
[Postmortem diagnosis of mixed respiratory virus infections in children]. Vopr Virusol (1976) 0.75
[Association of herpetic infection with respiratory viral infections in children]. Pediatriia (1975) 0.75
[Pneumonia in adults with influenza A2]. Ter Arkh (1979) 0.75
[Modern methods of the diagnosis of serum hepatitis type B]. Sov Med (1979) 0.75
[Sinusitis during para-influenza and Hong Kong 68 influenza A2]. Vestn Otorinolaringol (1971) 0.75
[Criteria for the severity of viral hepatitis]. Ter Arkh (1979) 0.75
[Cytological study of the upper respiratory tract epithelium in acute respiratory viral diseases]. Sov Med (1970) 0.75
[Rosette formation test for evaluating the immunological state of serum hepatitis patients]. Vopr Virusol (1979) 0.75
[Viral genome expression in mitochondria of patients with serum hepatitis]. Vopr Virusol (1974) 0.75
[Hepatitis B virus antigens and antibodies in acute infection]. Vopr Virusol (1980) 0.75
[Course of acute pneumonias in influenza patients with different bacterial associations]. Sov Med (1982) 0.75
[Comparison of immunofluorescent and morphological studies in lethal outcome of aucte respiratory viral diseases in children]. Pediatriia (1975) 0.75
[Serologic study of Mycoplasma pneumoniae infection in various age groups of adults and children]. Vopr Virusol (1969) 0.75
[Role of the infectious-disease specialist of a polyclinic in reducing the incidence of communicable diseases]. Ter Arkh (1977) 0.75
[Clinical aspects of severe forms of serum hepatitis type B]. Klin Med (Mosk) (1980) 0.75
[Fast postmortem diagnosis of adenovirus, para-influenza respiratory-syncytial virus diseases in children]. Vopr Okhr Materin Det (1971) 0.75
[Clinico-morphological comparisons in para-influenza]. Sov Med (1975) 0.75
[Determination of viremia in patients with para-influenza by immunofluorescence technic]. Vopr Virusol (1977) 0.75
[Glutamate dehydrogenase activity in the blood serum in viral hepatitis and other liver diseases]. Sov Med (1974) 0.75
[Treatment of acute liver dystrophy in viral hepatitis in pregnant women]. Ter Arkh (1976) 0.75
[Use of peroxidase and FITC labeled antibodies for express-diagnosis of influenza]. Vopr Virusol (1979) 0.75
[Value of IgM and IgG class anti-HBs in the differential diagnosis of viral hepatitis B and "non-A, non-B"]. Vopr Virusol (1982) 0.75
[Clinico-morphologic correlations in para-influenza]. Sov Med (1975) 0.75
[Use of the method of express-diagnosis in acute and lingering courses of respiratory-syncytial viral infections in children]. Vopr Okhr Materin Det (1975) 0.75
[Role of viral and viral-bacterial associations in the course of acute pneumonias in respiratory viral infections in young infants]. Pediatriia (1980) 0.75
[Non-A, non-B hepatitis: a new form of serum hepatitis]. Vopr Virusol (1981) 0.75
[Course of mixed influenza-adenovirus infection in adults]. Klin Med (Mosk) (1973) 0.75
[The role of air currents in the spread of viral respiratory infections in hospitals]. Zh Mikrobiol Epidemiol Immunobiol (1974) 0.75
[Basic research trends in the problem of "Viral Hepatitis"]. Vopr Virusol (1979) 0.75
[Pulmonary diffusion capacity in Hong Kong A2 influenza]. Sov Med (1971) 0.75
[Study of therapeutic effect of L-glutamine in acute viral hepatitis]. Ter Arkh (1972) 0.75
[Use of the method of perfusion through a heteroliver in the treatment of acute hepatic insufficiency in serum hepatitis]. Klin Med (Mosk) (1971) 0.75
[Clinico-laboratory study of different variants of hospitalization of children with acute respiratory virus infections]. Pediatriia (1970) 0.75
[HB antigen e in acute hepatitis B]. Vopr Virusol (1979) 0.75
[Study of respiratory function in acute pneumonias related to Eaton's agent]. Sov Med (1971) 0.75
[Acid-base balance and gas composition of the blood in severe forms of respiratory viral diseases in children]. Pediatriia (1977) 0.75
[Features of the clinical course of bronchitis in respiratory syncytial viral disease in children]. Pediatriia (1971) 0.75
[Acute pneumonia in influenza and other respiratory viral diseases]. Ter Arkh (1975) 0.75
[Electron microscopic study of the epithelium of the upper respiratory passages in patients with acute respiratory virus infections]. Vopr Virusol (1970) 0.75
[Clinico-immunological variants of acute hepatitis B]. Sov Med (1980) 0.75
[Improvements in the laboratory diagnosis of hemorrhagic fever with a renal syndrome]. Vopr Virusol (1982) 0.75
[Results of tests for detection of herpetic infection in patients with viral hepatitis and other liver diseases]. Klin Med (Mosk) (1974) 0.75
[Characteristics and the clinical pathogenetic sequelae of hepatitis B viral infection in newborn infants]. Pediatriia (1980) 0.75
[Etiologic role of cytomegalovirus in infectious mononucleosis and certain viral diseases]. Sov Med (1975) 0.75
[Late outcome of hepatitis B]. Ter Arkh (1980) 0.75
[Study of mycoplasma pneumonia]. Klin Med (Mosk) (1968) 0.75
[Detection of influenza antigen in intracellular inclusions by the I-131 labelled antibody method]. Vopr Virusol (1969) 0.75
[Experimental rhinovirus infection in man]. Vopr Virusol (1968) 0.75
[Immunologic memory in influenza patients according to the blast transformation reaction to specific antigen]. Vopr Virusol (1979) 0.75